Topics

"Fast and Furious" Development of Novel Approaches Changes Face of Myeloma Treatment

14:39 EST 4 Dec 2019 | OncLive

In an era of personalized medicine in oncology, monoclonal antibodies, bispecific T-cell engagers, and CAR T-cell therapies are revolutionizing patient outcomes in multiple myeloma.

Original Article: "Fast and Furious" Development of Novel Approaches Changes Face of Myeloma Treatment

NEXT ARTICLE

More From BioPortfolio on ""Fast and Furious" Development of Novel Approaches Changes Face of Myeloma Treatment"

Quick Search

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Monoclonal antibodies MAbs
Monoclonal antibodies recognise and attach to specific proteins produced by cells.  Types of monoclonal antibodies used to treat cancer cells: Block cell dividing dividing signals Transport cancer drugs or radiation to cancer cells Tr...